These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

486 related items for PubMed ID: 23857513

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Advanced [(18)F]FDG and [(11)C]flumazenil PET analysis for individual outcome prediction after temporal lobe epilepsy surgery for hippocampal sclerosis.
    Yankam Njiwa J, Gray KR, Costes N, Mauguiere F, Ryvlin P, Hammers A.
    Neuroimage Clin; 2015; 7():122-31. PubMed ID: 25610774
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic Performance of Positron Emission Tomography for the Presurgical Evaluation of Patients with Non-lesional Intractable Partial Epilepsy: Comparison among 18F-FDG, 11C-Flumazenil, and 11C-Flumazenil Binding Potential Imaging Using Statistical Imaging Analysis.
    Komoto D, Iida K, Higaki T, Kaichi Y, Takauchi K, Arihiro K, Kakita A, Hirokawa Y, Awai K.
    Hiroshima J Med Sci; 2015 Dec; 64(4):51-7. PubMed ID: 26964154
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical utility of 11C-flumazenil positron emission tomography in intractable temporal lobe epilepsy.
    Padma MV, Simkins R, White P, Satter M, Christian BT, Dunigan K, Lee C, Jacobs M, Mukherjee J, Mantil JC.
    Neurol India; 2004 Dec; 52(4):457-62. PubMed ID: 15626833
    [Abstract] [Full Text] [Related]

  • 6. Glucose and [11C]flumazenil positron emission tomography abnormalities of thalamic nuclei in temporal lobe epilepsy.
    Juhász C, Nagy F, Watson C, da Silva EA, Muzik O, Chugani DC, Shah J, Chugani HT.
    Neurology; 1999 Dec 10; 53(9):2037-45. PubMed ID: 10599778
    [Abstract] [Full Text] [Related]

  • 7. Regional hippocampal [11C]flumazenil PET in temporal lobe epilepsy with unilateral and bilateral hippocampal sclerosis.
    Koepp MJ, Labbé C, Richardson MP, Brooks DJ, Van Paesschen W, Cunningham VJ, Duncan JS.
    Brain; 1997 Oct 10; 120 ( Pt 10)():1865-76. PubMed ID: 9365376
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reduced synaptic vesicle protein 2A binding in temporal lobe epilepsy: A [11 C]UCB-J positron emission tomography study.
    Finnema SJ, Toyonaga T, Detyniecki K, Chen MK, Dias M, Wang Q, Lin SF, Naganawa M, Gallezot JD, Lu Y, Nabulsi NB, Huang Y, Spencer DD, Carson RE.
    Epilepsia; 2020 Oct 10; 61(10):2183-2193. PubMed ID: 32944949
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Performance of PET imaging for the localization of epileptogenic zone in patients with epilepsy: a meta-analysis.
    Niu N, Xing H, Wu M, Ma Y, Liu Y, Ba J, Zhu S, Li F, Huo L.
    Eur Radiol; 2021 Aug 10; 31(8):6353-6366. PubMed ID: 33523306
    [Abstract] [Full Text] [Related]

  • 13. [11C]Flumazenil PET in temporal lobe epilepsy: do we need an arterial input function or kinetic modeling?
    Hammers A, Panagoda P, Heckemann RA, Kelsch W, Turkheimer FE, Brooks DJ, Duncan JS, Koepp MJ.
    J Cereb Blood Flow Metab; 2008 Jan 10; 28(1):207-16. PubMed ID: 17579659
    [Abstract] [Full Text] [Related]

  • 14. Pre-surgical identification of epileptogenic areas in temporal lobe epilepsy by 123I-iomazenil SPECT: a comparison with IMP SPECT and FDG PET.
    Kaneko K, Sasaki M, Morioka T, Koga H, Abe K, Sawamoto H, Ohya N, Yoshiura T, Mihara F, Honda H.
    Nucl Med Commun; 2006 Nov 10; 27(11):893-9. PubMed ID: 17021430
    [Abstract] [Full Text] [Related]

  • 15. PET imaging of brain 5-HT1A receptors in the preoperative evaluation of temporal lobe epilepsy.
    Didelot A, Ryvlin P, Lothe A, Merlet I, Hammers A, Mauguière F.
    Brain; 2008 Oct 10; 131(Pt 10):2751-64. PubMed ID: 18790822
    [Abstract] [Full Text] [Related]

  • 16. Seizure outcomes in relation to the extent of resection of the perifocal fluorodeoxyglucose and flumazenil PET abnormalities in anteromedial temporal lobectomy.
    Stanišić M, Coello C, Ivanović J, Egge A, Danfors T, Hald J, Heminghyt E, Mikkelsen MM, Krossnes BK, Pripp AH, Larsson PG.
    Acta Neurochir (Wien); 2015 Nov 10; 157(11):1905-16. PubMed ID: 26350516
    [Abstract] [Full Text] [Related]

  • 17. Decreased dopamine D2/D3-receptor binding in temporal lobe epilepsy: an [18F]fallypride PET study.
    Werhahn KJ, Landvogt C, Klimpe S, Buchholz HG, Yakushev I, Siessmeier T, Müller-Forell W, Piel M, Rösch F, Glaser M, Schreckenberger M, Bartenstein P.
    Epilepsia; 2006 Aug 10; 47(8):1392-6. PubMed ID: 16922886
    [Abstract] [Full Text] [Related]

  • 18. Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy.
    Muzik O, da Silva EA, Juhasz C, Chugani DC, Shah J, Nagy F, Canady A, von Stockhausen HM, Herholz K, Gates J, Frost M, Ritter F, Watson C, Chugani HT.
    Neurology; 2000 Jan 11; 54(1):171-9. PubMed ID: 10636144
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Longitudinal changes of focal cortical glucose hypometabolism in adults with chronic drug resistant temporal lobe epilepsy.
    Sharpe C, Sinclair B, Kwan P, Hicks RJ, O'Brien TJ, Vivash L.
    Brain Imaging Behav; 2021 Dec 11; 15(6):2795-2803. PubMed ID: 34671889
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.